MoneyWorks4Me

NGL Fine-Chem - Quaterly Results

22 May 2025 Evaluate
Revenue showed a marginal decline at Rs. 930.18 millions. For the quarter ended March 2025, as compared to corresponding quarter of last year.The Net Loss for the quarter ended March 2025 is Rs. -5.20 millions as compared to Net Profit of Rs. 108.50 millions of corresponding quarter ended March 2024Operating profit for the quarter ended March 2025 decreased to 31.19 millions as compared to 167.60 millions of corresponding quarter ended March 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 930.18 956.09 -2.71 3592.94 3289.73 9.22 3592.94 3289.73 9.22
Other Income -7.90 41.64 -118.97 97.58 159.01 -38.63 97.58 159.01 -38.63
PBIDT 31.19 167.60 -81.39 354.59 601.94 -41.09 354.59 601.94 -41.09
Interest 9.47 4.58 106.77 23.07 13.38 72.42 23.07 13.38 72.42
PBDT 21.72 163.02 -86.68 331.52 588.56 -43.67 331.52 588.56 -43.67
Depreciation 25.32 20.64 22.67 92.70 81.48 13.77 92.70 81.48 13.77
PBT -3.60 142.38 -102.53 238.82 507.08 -52.90 238.82 507.08 -52.90
TAX 1.60 33.88 -95.28 57.50 121.89 -52.83 57.50 121.89 -52.83
Deferred Tax 4.16 1.13 268.14 4.06 7.76 -47.68 4.06 7.76 -47.68
PAT -5.20 108.50 -104.79 181.32 385.19 -52.93 181.32 385.19 -52.93
Equity 30.89 30.89 0.00 30.89 30.89 0.00 30.89 30.89 0.00
PBIDTM(%) 3.35 17.53 -80.87 9.87 18.30 -46.06 9.87 18.30 -46.06
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..